Protein arginine methyltransferase 5 is implicated in the aggressiveness of human hepatocellular carcinoma and controls the invasive activity of cancer cells
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeon, Ju-Yeon | - |
dc.contributor.author | Lee, Jee San | - |
dc.contributor.author | Park, Eun-Ran | - |
dc.contributor.author | Shen, Yan Nan | - |
dc.contributor.author | Kim, Mi-Yeun | - |
dc.contributor.author | Shin, Hyun-Jin | - |
dc.contributor.author | Joo, Hyun-Yoo | - |
dc.contributor.author | Cho, Eung-Ho | - |
dc.contributor.author | Moon, Sun Mi | - |
dc.contributor.author | Shin, Ui Sup | - |
dc.contributor.author | Park, Sun Hoo | - |
dc.contributor.author | Han, Chul Ju | - |
dc.contributor.author | Choi, Dong Wook | - |
dc.contributor.author | Gu, Man Bock | - |
dc.contributor.author | Kim, Sang-Bum | - |
dc.contributor.author | Lee, Kee-Ho | - |
dc.date.accessioned | 2021-09-02T09:14:32Z | - |
dc.date.available | 2021-09-02T09:14:32Z | - |
dc.date.created | 2021-06-16 | - |
dc.date.issued | 2018-07 | - |
dc.identifier.issn | 1021-335X | - |
dc.identifier.uri | https://scholar.korea.ac.kr/handle/2021.sw.korea/74463 | - |
dc.description.abstract | Protein arginine methyltransferase 5 (PRMT5) is a protein that catalyzes transfer of methyl groups to the arginine residues of proteins and is involved in diverse cellular and biological responses. While the participation of PRMT5 in cancer progression has been increasingly documented, its association with the invasive phenotype currently remains poorly understood. In the present study, we revealed that PRMT5 is overexpressed in human hepatocellular carcinoma (HCC) and in colon cancer and its depletion leads to the suppression of cell invasive activity via the reduction of the expression of MMP-2. Real-time quantitative RT-PCR analysis of 120 HCC patient tissues revealed the overexpression of PRMT5 in HCC and the association of PRMT5 with aggressive clinicopathological parameters, such as poorer differentiation (P=0.004), more frequent hepatic vein invasion (P=0.019), larger tumor size (P=0.011) and higher -fetoprotein levels (P=0.020). Similarly to the data obtained with HCC, overexpression of PRMT5 was also displayed in colon cancer tissues, compared to matched non-tumor regions. Consistent with the significant association of the overexpression of PRMT5 with hepatic vein invasion in patient specimens, PRMT5 depletion via siRNA transfection led to a marked reduction in the invasion rate in both HCC and colon cancer cells. Reduced invasion associated with PRMT5 depletion was accompanied by a decrease in the expression of MMP-2. Collectively, our results indicated that PRMT5 overexpression in HCC and colon cancer cells contributed to their acquisition of aggressive characteristics, such as invasiveness, thus presenting a promising therapeutic target for the treatment of these diseases. | - |
dc.language | English | - |
dc.language.iso | en | - |
dc.publisher | SPANDIDOS PUBL LTD | - |
dc.subject | TRANSCRIPTIONAL ACTIVATION | - |
dc.subject | MALIGNANT PHENOTYPE | - |
dc.subject | METHYLATION | - |
dc.subject | PRMT5 | - |
dc.subject | EXPRESSION | - |
dc.subject | GROWTH | - |
dc.subject | SUPPRESSES | - |
dc.subject | LOCALIZATION | - |
dc.subject | PROGNOSIS | - |
dc.subject | INTEGRIN | - |
dc.title | Protein arginine methyltransferase 5 is implicated in the aggressiveness of human hepatocellular carcinoma and controls the invasive activity of cancer cells | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Gu, Man Bock | - |
dc.identifier.doi | 10.3892/or.2018.6402 | - |
dc.identifier.scopusid | 2-s2.0-85047950028 | - |
dc.identifier.wosid | 000440584300053 | - |
dc.identifier.bibliographicCitation | ONCOLOGY REPORTS, v.40, no.1, pp.536 - 544 | - |
dc.relation.isPartOf | ONCOLOGY REPORTS | - |
dc.citation.title | ONCOLOGY REPORTS | - |
dc.citation.volume | 40 | - |
dc.citation.number | 1 | - |
dc.citation.startPage | 536 | - |
dc.citation.endPage | 544 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Oncology | - |
dc.relation.journalWebOfScienceCategory | Oncology | - |
dc.subject.keywordPlus | TRANSCRIPTIONAL ACTIVATION | - |
dc.subject.keywordPlus | MALIGNANT PHENOTYPE | - |
dc.subject.keywordPlus | METHYLATION | - |
dc.subject.keywordPlus | PRMT5 | - |
dc.subject.keywordPlus | EXPRESSION | - |
dc.subject.keywordPlus | GROWTH | - |
dc.subject.keywordPlus | SUPPRESSES | - |
dc.subject.keywordPlus | LOCALIZATION | - |
dc.subject.keywordPlus | PROGNOSIS | - |
dc.subject.keywordPlus | INTEGRIN | - |
dc.subject.keywordAuthor | PRMT5 | - |
dc.subject.keywordAuthor | hepatocellular carcinoma | - |
dc.subject.keywordAuthor | colon cancer | - |
dc.subject.keywordAuthor | invasion | - |
dc.subject.keywordAuthor | alpha-fetoprotein | - |
dc.subject.keywordAuthor | differentiation | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
(02841) 서울특별시 성북구 안암로 14502-3290-1114
COPYRIGHT © 2021 Korea University. All Rights Reserved.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.